World's Best Scientists 2026 revealed!
Nicholas Pavlidis

Nicholas Pavlidis

D-Index & Metrics

Medicine

D-Index
81
Citations
23324
World Ranking
16683
National Ranking
45

Nicholas Pavlidis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicholas Pavlidis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 404 publications — 39th percentile

39% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicholas Pavlidis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas Pavlidis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 81 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicholas Pavlidis is affiliated with the University of Ioannina in Greece and has contributed extensively to the field of medicine, particularly focusing on oncology. Their published work spans a variety of subfields, including oncology, pathology and forensic medicine, radiology, nuclear medicine and imaging, oral surgery, and pulmonary and respiratory medicine.

Their research addresses numerous key topics such as cancer diagnosis and treatment, tumors and oncological cases, oral and maxillofacial pathology, advances in oncology and radiotherapy, innovations in medical education, PARP inhibition in cancer therapy, and ovarian cancer diagnosis and treatment.

Recent papers authored or co-authored by Pavlidis include:

  • Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond, 2020, published in Drugs in R&D
  • Progress in refining the clinical management of cancer of unknown primary in the molecular era, 2020, published in Nature Reviews Clinical Oncology
  • BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside, 2022, published in Cancers
  • New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?, 2020, published in Critical Reviews in Oncology/Hematology
  • Melanoma of unknown primary: New perspectives for an old story, 2020, published in Critical Reviews in Oncology/Hematology

Pavlidis has frequently collaborated with several researchers, including:

  • Elie Rassy
  • Stergios Boussios
  • Fedro A. Peccatori
  • Alberto Costa
  • Matti Aapro

Their work has been published repeatedly in notable scientific venues such as:

  • Critical Reviews in Oncology/Hematology
  • Journal of Cancer Education
  • European Journal of Cancer
  • Annals of Translational Medicine
  • Future Oncology

Best Publications

  • Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis

    Davide Mauri;Nicholas Pavlidis;John P. A. Ioannidis

  • Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. A. Peccatori;H. A. Azim;R. Orecchia;Harald Hoekstra

  • Diagnostic and therapeutic management of cancer of an unknown primary

    N. Pavlidis;E. Briasoulis;J. Hainsworth;F.A. Greco

  • Coexistence of pregnancy and malignancy.

    Nicholas A. Pavlidis

  • Cancer of unknown primary site

    Nicholas Pavlidis;George Pentheroudakis

  • Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

    K. Fizazi;F. A. Greco;N. Pavlidis;G. Daugaard

  • Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

    Davide Mauri;Nicholas Pavlidis;Nikolaos P. Polyzos;John P. A. Ioannidis

  • Cancer and pregnancy: Poena magna, not anymore

    George Pentheroudakis;Nicholas Pavlidis

  • Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies.

    Hatem A. Azim;Luigi Santoro;Nicholas Pavlidis;Shari Gelber

  • Switching benchmarks in cancer of unknown primary: From autopsy to microarray

    George Pentheroudakis;Vassilios Golfinopoulos;Nicholas Pavlidis

  • Carcinoma of unknown primary (CUP)

    Nicholas Pavlidis;Karim Fizazi

  • Prognosis of pregnancy-associated breast cancer: A meta-analysis of 30 studies

    Hatem A. Azim;Luigi Santoro;William Russell-Edu;George Pentheroudakis

  • REGULATION OF MACROPHAGE TUMORICIDAL FUNCTION- A ROLE FOR PROSTAGLANDINS OF THE E SERIES

    R. M. Schultz;N. A. Pavlidis;W. A. Stylos;M. A. Chirigos

  • Carboplatin plus paclitaxel in unknown primary carcinoma : A phase II hellenic cooperative oncology group study

    Evangelos Briasoulis;Haralambos Kalofonos;Dimitris Bafaloukos;Epaminondas Samantas

  • Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.

    Nicholas A. Pavlidis;Christos Petris;Evagellos Briassoulis;George Klouvas

  • Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors

    Hatem A. Azim;Nicholas Pavlidis;Fedro A. Peccatori

  • Survival and disease-progression benefits with treatment regimens for advanced colorectal cancer: a meta-analysis.

    Vassilis Golfinopoulos;Georgia Salanti;Nicholas Pavlidis;John P A Ioannidis

  • Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

    Maria Kyrgiou;Georgia Salanti;Nicholas Pavlidis;Evangelos Paraskevaidis

  • Cancer of unknown primary (CUP).

    Nicholas Pavlidis;Karim Fizazi

  • Effect of letrozole on the lipid profile in postmenopausal women with breast cancer.

    M.S Elisaf;E.Th Bairaktari;C Nicolaides;B Kakaidi

Frequent Co-Authors

George Fountzilas
George Fountzilas Aristotle University of Thessaloniki
John P. A. Ioannidis
John P. A. Ioannidis Stanford University
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Thomas Hyphantis
Thomas Hyphantis University of Ioannina
Helen Gogas
Helen Gogas National and Kapodistrian University of Athens
Matti Aapro
Matti Aapro European CanCer Organisation
Richard M. Schultz
Richard M. Schultz University of Pennsylvania
Alexandros A. Drosos
Alexandros A. Drosos University of Ioannina
Andrés Cervantes
Andrés Cervantes University of Valencia
Jonas Bergh
Jonas Bergh Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to a wide variety of healthcare-related roles beyond traditional medical school. For those interested in nutrition, consider one of the best online food science degree options, which provide a flexible route to careers in wellness, food safety, and dietetics.

For professionals seeking leadership opportunities in healthcare, accredited programs matter. Explore this cahme accredited online mha programs list to find high-quality Master of Health Administration degrees offered fully online, making it easier for working adults to advance their skills.

Registered Nurses aiming to earn a bachelor’s degree without the burden of additional clinical rotations can now benefit from the best online rn to bsn programs without clinical requirements. These programs are ideal for those balancing work and study.

If you’re looking for the fastest route to advanced practice, check out the shortest dnp programs available online. Short, intensive pathways help experienced nurses achieve top-level training and credentials efficiently.

Each of these online pathways offers unique advantages for students planning a flexible and rewarding healthcare career.

Best Scientists Citing Nicholas Pavlidis

Trending Scientists

Recently Published Articles